sb 203580 has been researched along with acid phosphatase in 6 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (acid phosphatase) | Trials (acid phosphatase) | Recent Studies (post-2010) (acid phosphatase) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 24,029 | 223 | 1,701 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ostrowski, MC; Patel, K; Rosol, TJ; Sankar, U | 1 |
| Ariyoshi, W; Ichimiya, H; Kanno, T; Koseki, T; Nishihara, T; Takahashi, T; Takano, H | 1 |
| Agler, ML; Chen, T; Dickson, JK; Feyen, JH; Huang, J; Knapp, AC; Lawrence, RM; Lynch, JS; Wu, Y | 1 |
| Ekuni, D; Ii, H; Imai, T; Irie, K; Morita, M; Yaegaki, K | 1 |
| Chen, D; Guo, Y; Mao, X; Zhang, X | 1 |
| Choi, J; Choi, SY; Kim, HS; Lee, JY; Lee, NK; Lee, SY | 1 |
6 other study(ies) available for sb 203580 and acid phosphatase
| Article | Year |
|---|---|
RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Blotting, Western; Bone Marrow Cells; Carrier Proteins; Cathepsin K; Cathepsins; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chromones; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p18; Cyclin-Dependent Kinase Inhibitor p19; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Enzyme Inhibitors; Femur; Flavonoids; Gene Expression; Imidazoles; Isoenzymes; Macrophage Colony-Stimulating Factor; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Osteoclasts; Osteopetrosis; Pyridines; Radiography; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Reverse Transcriptase Polymerase Chain Reaction; Tartrate-Resistant Acid Phosphatase; Tumor Suppressor Proteins | 2004 |
Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid.
Topics: Acid Phosphatase; Animals; Antibodies, Monoclonal; Blotting, Western; Bone Resorption; Carrier Proteins; Cell Differentiation; Cell Line; Cell Survival; CSK Tyrosine-Protein Kinase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Matrix; Hyaluronan Receptors; Hyaluronic Acid; Imidazoles; Isoenzymes; Membrane Glycoproteins; Mice; Molecular Weight; Monocytes; Osteoclasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein-Tyrosine Kinases; Pyridines; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction; src-Family Kinases; Tartrate-Resistant Acid Phosphatase; Time Factors; Up-Regulation | 2005 |
High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitor.
Topics: Acid Phosphatase; Animals; Cell Line; Cell Line, Tumor; Cell Survival; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression; Humans; Imidazoles; Isoenzymes; Lipopolysaccharides; Luciferases; Nitroimidazoles; Osteoclasts; Osteoprotegerin; Pyridines; RANK Ligand; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tartrate-Resistant Acid Phosphatase; Tumor Necrosis Factor-alpha | 2006 |
Oral malodorous compound induces osteoclast differentiation without receptor activator of nuclear factor κB ligand.
Topics: Acid Phosphatase; Animals; Blotting, Western; Calcium Phosphates; Calcium-Calmodulin-Dependent Protein Kinases; Cathepsin K; Cell Differentiation; Cell Line; Enzyme Inhibitors; Flavonoids; Halitosis; Hydrogen Sulfide; Imidazoles; Isoenzymes; Macrophages; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoclasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; RANK Ligand; Tartrate-Resistant Acid Phosphatase | 2010 |
Inhibition of p38 mitogen-activated protein kinase down-regulates the inflammatory osteolysis response to titanium particles in a murine osteolysis model.
Topics: Acid Phosphatase; Animals; Bone and Bones; Down-Regulation; Enzyme Inhibitors; Female; Imidazoles; Inflammation; Isoenzymes; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Osteoclasts; Osteolysis; p38 Mitogen-Activated Protein Kinases; Pyridines; RNA, Messenger; Tartrate-Resistant Acid Phosphatase; Titanium; Tumor Necrosis Factor-alpha | 2012 |
Caffeine enhances osteoclast differentiation and maturation through p38 MAP kinase/Mitf and DC-STAMP/CtsK and TRAP pathway.
Topics: Acid Phosphatase; Animals; Caffeine; Cathepsin K; Cell Differentiation; Cell Line; Gene Expression; Imidazoles; Isoenzymes; Membrane Proteins; Mice; Mice, Inbred C57BL; Microphthalmia-Associated Transcription Factor; Nerve Tissue Proteins; NFATC Transcription Factors; Osteoclasts; Osteogenesis; p38 Mitogen-Activated Protein Kinases; Pyridines; RANK Ligand; Receptors, Cell Surface; Signal Transduction; Tartrate-Resistant Acid Phosphatase | 2013 |